This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cui J, Arita Y, Bystryn JC (1993) Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 100:812–815
Dave S, Thappa DM, Dsouza M (2002) Clinical predictors of outcome in vitiligo. Indian J Dermatol Venereol Leprol 68:323–325
Halder RM, Grimes PE, Cowan CA (1987) Childhood viti-ligo. J Am Acad Dermatol 16:948–954
Hann SK, Chun WH, Park YK (1997) Clinical characteristics of progressive vitiligo. Int J Dermatol 36:353–355
Hann SK, Kim YS, Yoo JH, Chun YS (2000) Clinical and histopathologic characteristics of trichrome vitiligo J Am Acad Dermatol 42:589–596
Hann SK, Lee HJ (1996) Segmental vitiligo: clinical find-ings in 208 patients. J Am Acad Dermatol 35:671–674
Hann SK, Park YK, Whang KC (1986) Clinical study of 174 patients with generalized vitiligo. Kor J Dermatol 24:798–805
Harning R, Cui J, Bystryn JC (1991) Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 97:1078–1080
Hatchome N, Kato T, Tagamit H (1990) Therapeutic success of epidermal grafting in generalized vitiligo is limited by the Koebner phenomenon. J Am Acad Dermatol 22:87–91
Falabella R, Arrunategui A, Barona MI, Alzate A (1995) The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation. J Am Acad Dermatol 32:228–232
Gauthier Y (1995) The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions. Eur J Dermatol 5:704–708
Koga M (1977) Vitiligo: a new classification and therapy. Br J Dermatol 97:255–261
Koga M, Tango T (1988) Clinical feature and course of type A and type B vitiligo. Br J Dermatol 118:223–228
Moellmann G, Klein-Angerer S, Scollay DA et al (1982) Extracellular granular material and degeneration of kerati-nocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 79:321–330
Njoo MD, Das PK, Bos JD, Westerhof W (1999) Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 135:407–413
Ortonne JP (2000) Special features of vitiligo. In: Hann SK, Nordlund JJ (eds) Vitiligo. A monograph on the basic and clinical science. Blackwell, Oxford, pp 70–77
Parsad D, Kanwar AJ, Kumar B (2006) Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treat- ment of vitiligo. J Eur Acad Dermatol Venereol 20:175–177
Parsad D, Pandhi R, Dogra S, Kumar B (2004) Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol 50:63–67
Parsad D, Pandhi R, Juneja A (2003) Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 28:285–287
Taïeb A, Picardo M; VETF Members (2007) The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20:27–35
Uda H, Takei M, Mishima Y (1984) Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects, II: the IgG and C3 deposits in the skin. J Cutan Pathol 11:114–124
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Parsad, D. (2010). Natural History and Prognosis. In: Picardo, M., Taïeb, A. (eds) Vitiligo. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69361-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-540-69361-1_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69360-4
Online ISBN: 978-3-540-69361-1
eBook Packages: MedicineMedicine (R0)